Results
1 -
10 of
19Dihydropyrimidine Dehydrogenase in Livers from Mouse and Rat, and in Human Liver, Colon Tumors, and Mucosa in Relation to Anabolism of 5-Fluorouracil, Purine and Pyrimidine Metabolism in Man IX Intraoperative Chemotherapie zur Bestimmung unterschiedlicher Cytotoxizit??t von 5-FU im Lebermetastasengewebe von Patienten mittels 19-F-Hochfeld MR-Spektroskopie, 107. Kongre?? der Deutschen Gesellschaft f??r Chirurgie Berlin, 17.u201321. April 1990 Noninvasive fluorine-19 NMR study of fluoropyrimidine metabolism in cell cultures of human pancreatic and colon adenocarcinoma, Cancer Chemotherapy and Pharmacology Measurement of in vitro cellular pharmacokinetics of 5-fluorouracil in human and rat cancer cell lines and rat hepatocytes using a flow-through system, Cancer Chemotherapy and Pharmacology Reduction of the antineoplastic fluoropoyrimidine, 5-fluorouracil, to 5,6-dihydro-5-fluorouracil inEscherichia coli, Biotechnology Letters The contribution of deleterious DPYD gene sequence variants to fluoropyrimidine toxicity in British cancer patients, Cancer Chemotherapy and Pharmacology Accumulation of alpha-fluoro-beta-alanine and fluoro mono acetate in a patient with 5-fluorouracil-associated hyperammonemia, Cancer Chemotherapy and Pharmacology Severe 5-fluorouracil toxicity associated with a marked alteration of pharmacokinetics of 5-fluorouracil and its catabolite 5-fluoro-5,6-dihydrouracil: a case report, European Journal of Clinical Pharmacology Determination of 5-fluorouracil and dihydrofluorouracil levels by using a liquid chromatographyu2013tandem mass spectrometry method for evaluation of dihydropyrimidine dehydrogenase enzyme activity, Cancer Chemotherapy and Pharmacology Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study, Cancer Chemotherapy and Pharmacology